Yabao Pharmaceuticals and Salus Pharma announce strategic partnership for generic drugs
Yabao Pharmaceuticals is a leading Chinese pharmaceutical company with fully integrated development, manufacturing and commercialisation capabilities
Yabao Pharmaceutical Co, Inc.and Salus Pharma have announced a strategic partnership to co-develop, manufacture and commercialise high technological barrier generic drugs worldwide.
Under the terms of the agreement, Yabao will exclusively own rights to commercialise certain Salus Pharma-developed products outside the US and to manufacture for worldwide markets, while Salus Pharma will retain rights to commercialise in the US. Financial terms were not disclosed.
‘Yabao is excited to collaborate with Salus Pharma, a specialty pharmaceutical company engaged in the research and development of high technological barrier controlled release formulation. This transaction represents our first generic drug partnership with Salus this year,’commented Dr Peng Wang, President of R&D and Head of International Business, Yabao Pharmaceutical Co. ‘This partnership further demonstrates that Yabao’s competitive R&D and manufacturing have expanded into developed markets.’
